Detalhe da pesquisa
1.
KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target.
Blood
; 140(13): 1522-1532, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687761
2.
Real-life targeted next-generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network.
Br J Haematol
; 193(6): 1110-1122, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764507
3.
Therapeutic options in VEXAS syndrome: insights from a retrospective series.
Blood
; 137(26): 3682-3684, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619558
4.
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?
Hematol Oncol
; 36(2): 399-406, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28983943
5.
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes.
Hematol Oncol
; 2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29722049
6.
VEXAS syndrome-related AA amyloidosis: a case report.
Rheumatology (Oxford)
; 61(1): e15-e16, 2021 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34498034
7.
VEXAS syndrome in a woman.
Rheumatology (Oxford)
; 60(11): e402-e403, 2021 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930131
8.
Next-CLL, a New Next-Generation Sequencing-Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia.
J Mol Diagn
; 25(5): 274-283, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773701
9.
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood Adv
; 7(5): 744-755, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439292
10.
CAR-T cells, from principle to clinical applications.
Bull Cancer
; 108(10S): S4-S17, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34920806
11.
How to Obtain a High Quality ctDNA in Lymphoma Patients: Preanalytical Tips and Tricks.
Pharmaceuticals (Basel)
; 14(7)2021 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34206947
12.
Toward a pathophysiology inspired treatment of VEXAS syndrome.
Semin Hematol
; 58(4): 239-246, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34802546
13.
Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
Blood Adv
; 5(16): 3227-3239, 2021 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34427583
14.
Polatuzumab vedotin: an investigational anti-CD79b antibody drug conjugate for the treatment of diffuse large B-cell lymphoma.
Expert Opin Investig Drugs
; 29(10): 1079-1088, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700972
15.
Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome.
Hemasphere
; 7(2): e828, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36751512
16.
Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas.
Leuk Lymphoma
; 64(3): 707-711, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36573418
17.
Atypical extensive lupus tumidus-like eruption as an early presentation of VEXAS syndrome.
Int J Dermatol
; 61(3): e89-e91, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587282